dichlororibofuranosylbenzimidazole has been researched along with Cell Transformation, Neoplastic in 2 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapp, LN | 1 |
| Painter, RB | 1 |
| Coppock, DL | 1 |
| Pardee, AB | 1 |
1 review available for dichlororibofuranosylbenzimidazole and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
DNA replication fork movement rates in mammalian cells.
Topics: Animals; Autoradiography; Bloom Syndrome; Cell Line; Cell Transformation, Neoplastic; Centrifugation | 1982 |
1 other study available for dichlororibofuranosylbenzimidazole and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Regulation of thymidine kinase activity in the cell cycle by a labile protein.
Topics: Animals; Aphidicolin; Benzo(a)pyrene; Blood; Cell Cycle; Cell Transformation, Neoplastic; Cyclohexim | 1985 |